In the intricate supply chain of pharmaceutical manufacturing, sourcing reliable and high-quality Active Pharmaceutical Ingredient (API) intermediates is a paramount concern. These compounds form the foundational elements of life-saving medications, and any compromise in their purity or availability can have far-reaching consequences. One such critical intermediate is 2,4-Dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]-2-(2-methylpropyl)-3H-1,2,4-triazol-3-one, commonly identified by its CAS number 89848-21-5. As a leading manufacturer and supplier of this compound, we aim to shed light on what buyers need to consider when sourcing this vital chemical.
The primary consideration for any API intermediate is its purity. For CAS 89848-21-5, achieving a high level of purity, typically ≥99%, is essential for its successful integration into complex API synthesis pathways. Impurities can not only affect reaction yields but, more critically, can lead to the formation of undesirable byproducts or, in the worst-case scenario, render the final drug product unsafe or ineffective. As a manufacturer based in China, we employ stringent quality control protocols throughout our production process to guarantee the consistent delivery of a white powder intermediate that meets these exacting standards. This dedication to quality makes us a trusted source for buyers worldwide.
Reliability of supply is another non-negotiable factor. Pharmaceutical development often operates on tight schedules, and a disruption in the supply of a key intermediate can cause significant delays and financial losses. Buyers need to partner with suppliers who have a robust manufacturing capacity and a dependable logistical network. Our established production capabilities and efficient export operations ensure that we can meet both research-scale and commercial-scale demands for CAS 89848-21-5. When you decide to buy this intermediate, you are looking for a partner that ensures continuity.
Cost-effectiveness is, naturally, a significant driver in procurement. However, it must be viewed in conjunction with quality and reliability. The cheapest option might not always be the most economical in the long run if it leads to production issues or requires additional purification steps. We strive to offer a competitive wholesale price for pharmaceutical intermediates like CAS 89848-21-5, providing excellent value by balancing high quality with efficient manufacturing and supply chain management. Our aim is to be a cost-effective yet uncompromisingly high-quality supplier.
For procurement professionals seeking to buy 2,4-Dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]-2-(2-methylpropyl)-3H-1,2,4-triazol-3-one, engaging with experienced manufacturers and suppliers is crucial. Understanding the specifications, the manufacturing location, and the supplier's commitment to quality assurance will guide your decision. We encourage you to reach out to us to discuss your specific requirements for CAS 89848-21-5. As a leading manufacturer and supplier, we are dedicated to supporting your critical API intermediate needs.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.